<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 07/08/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 07/08/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Sylvia E Patrick</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">September 29, 1945 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>2136 BEAVERDAM RD<br/>WINTERVILLE, GA 30683-2811, US<br/><br/>Work Phone:  706-340-9318<br/>Primary Home Phone:  706-742-8585<br/>Mobile Phone:  706-612-4928<br/>Email:  selainepatrick@gmail.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">3595788 2.16.840.1.113883.4.391.318553<br/>3595788 2.16.840.1.113883.4.391.318553.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">fdd79b80-3fd2-400f-adaa-801c6b870b31 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">December 18, 2024, 13:14:09, EST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Karen Dixon, NP</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Tara Gulsby</td></tr><tr><td class="td_header_role_value internal_format">340 N Milledge Ave<br/>Suite B<br/>Athens, GA 306013806, US<br/><br/>Tel:  706-548-0008<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Melissa Baughcum</td></tr><tr><td class="td_header_role_value internal_format">340 N Milledge Ave<br/>Suite B<br/>Athens, GA 306013806, US<br/><br/>Tel:  706-548-0008<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">21275205 2.16.840.1.113883.4.391.318553</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From July 8, 2024, 11:20:00   to July 8, 2024, 11:40:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.318553</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Melissa Baughcum</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">340 N Milledge Ave<br/>Suite B<br/>Athens, GA 306013806, US<br/><br/>Tel:  706-548-0008<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">Shanna Colvin<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">2136 BEAVERDAM RD<br/>WINTERVILLE, GA 30683-2811, US<br/><br/>Tel:  706-340-9318<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">Sylvia Patrick<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  706-742-8585<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Melissa Baughcum signed at July 8, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">340 N Milledge Ave<br/>Suite B<br/>Athens, GA 306013806, US<br/><br/>Tel:  706-548-0008<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">United Digestive</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">10 Glenlake Parkway NE - North Tower<br/>Ste 900<br/>Atlanta, GA 30328-7249, US<br/><br/>Tel:  404-888-7575<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">REASON FOR VISIT</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Social History</a></li><li><a href="#id6">Vital Signs</a></li><li><a href="#id7">Encounters</a></li><li><a href="#id8">Assessments</a></li><li><a href="#id9">Plan Of Treatment</a></li><li><a href="#id10">Progress Notes</a></li><li><a href="#id11">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">Dander</td><td>Dander (uncoded)</td><td ID="reaction1">Notes: Pet Dander</td><td>Allergy</td><td>10/19/2016</td><td>Active</td></tr><tr><td ID="allergy2"/><td>Dust Mite (uncoded)</td><td ID="reaction2">Unknown</td><td>Allergy</td><td>10/19/2016</td><td>Active</td></tr><tr><td ID="allergy3">Substance with sulfonamide structure and antibacterial mechanism of action (substance)</td><td>SULFA (SULFONAMIDES) (uncoded)</td><td ID="reaction3">Unknown</td><td>Allergy</td><td>05/15/2012</td><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">CMP Comp. Metabolic Panel (14)</span><br/>Reviewed date:07/09/2024 06:41:24 PM<br/>Interpretation:<br/>Performing Lab:AT, Quest Diagnostics-Atlanta1777 Montreal Circle, TuckerGA30084-6802 Dr Andrew N Young<br/>Notes/Report:<br/>FASTING: NO<br/>FASTING:NO<br/>0; 0; 0</td></tr><tr><td ID="result1_attr1">EGFR</td><td>92</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td colspan="4"><span class="content_span">CBC w/Diff</span><br/>Reviewed date:07/09/2024 06:41:24 PM<br/>Interpretation:<br/>Performing Lab:AT, Quest Diagnostics-Atlanta1777 Montreal Circle, TuckerGA30084-6802 Dr Andrew N Young<br/>Notes/Report:<br/>0; 0; 0<br/>FASTING:NO<br/>FASTING: NO</td></tr><tr><td ID="result2_attr1">WHITE BLOOD CELL COUNT</td><td>3.9</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result2_attr2">RED BLOOD CELL COUNT</td><td>4.67</td><td>3.80-5.10 Million/uL</td><td/></tr><tr><td ID="result2_attr3">HEMOGLOBIN</td><td>12.9</td><td>11.7-15.5 g/dL</td><td/></tr><tr><td ID="result2_attr4">HEMATOCRIT</td><td>40.2</td><td>35.0-45.0 %</td><td/></tr><tr><td ID="result2_attr5">MCV</td><td>86.1</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result2_attr6">MCH</td><td>27.6</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result2_attr7">MCHC</td><td>32.1</td><td>32.0-36.0 g/dL</td><td/></tr><tr><td ID="result2_attr8">RDW</td><td>13.4</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result2_attr9">PLATELET COUNT</td><td>91</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result2_attr10">MPV</td><td>12.1</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result2_attr11">ABSOLUTE NEUTROPHILS</td><td>1950</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result2_attr12">ABSOLUTE LYMPHOCYTES</td><td>1283</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result2_attr13">ABSOLUTE MONOCYTES</td><td>499</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result2_attr14">ABSOLUTE EOSINOPHILS</td><td>129</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result2_attr15">ABSOLUTE BASOPHILS</td><td>39</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result2_attr16">NEUTROPHILS</td><td>50</td><td/><td/></tr><tr><td ID="result2_attr17">LYMPHOCYTES</td><td>32.9</td><td/><td/></tr><tr><td ID="result2_attr18">MONOCYTES</td><td>12.8</td><td/><td/></tr><tr><td ID="result2_attr19">EOSINOPHILS</td><td>3.3</td><td/><td/></tr><tr><td ID="result2_attr20">BASOPHILS</td><td>1.0</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">PT/INR</span><br/>Reviewed date:07/09/2024 06:41:24 PM<br/>Interpretation:<br/>Performing Lab:AT, Quest Diagnostics-Atlanta1777 Montreal Circle, TuckerGA30084-6802 Dr Andrew N Young<br/>Notes/Report:<br/>0; 0; 0<br/>FASTING:NO<br/>FASTING: NO</td></tr><tr><td ID="result3_attr1">INR</td><td>1.1</td><td/><td ID="result3_attr1_notes"><p>Reference Range                     0.9-1.1</p><p>Moderate-intensity Warfarin Therapy 2.0-3.0</p><p>Higher-intensity Warfarin Therapy   3.0-4.0</p></td></tr><tr><td ID="result3_attr2">PT</td><td>11.1</td><td>9.0-11.5 sec</td><td ID="result3_attr2_notes"><p>For additional information, please refer to</p><p>http://education.questdiagnostics.com/faq/FAQ104</p><p>(This link is being provided for informational/</p><p>educational purposes only.)</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">REASON FOR VISIT</a></h3><div>6m f/u</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">PEG-3350/Electrolytes 236 GM</td><td ID="instruction1">as directed Orally once for 1 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Zofran 4 MG</td><td ID="instruction2">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Omeprazole 20 MG</td><td ID="instruction3">1 capsule 30 minutes before morning meal Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Lisinopril 10 mg</td><td ID="instruction4">take 1 tablet (10 mg) by oral route once daily QD</td><td/><td>10/02/2015</td><td/><td>Active</td></tr><tr><td ID="medication5">Propranolol HCl 10 MG</td><td ID="instruction5">take 1 tablet (10 mg) by oral route QD Oral 3</td><td/><td>01/01/1900</td><td/><td>Active</td></tr><tr><td ID="medication6">Vitamin D (Ergocalciferol) 50000 UNIT</td><td ID="instruction6"> Oral</td><td/><td>01/01/1900</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Female</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Height</th><td>62 in</td><td>07/08/2024</td></tr><tr><th ID="vital2">Weight</th><td>194 lbs</td><td>07/08/2024</td></tr><tr><th ID="vital3">BMI</th><td>35.48 kg/m2</td><td>07/08/2024</td></tr><tr><th ID="vital4">Blood pressure systolic</th><td>155 mm Hg</td><td>07/08/2024</td></tr><tr><th ID="vital5">Blood pressure diastolic</th><td>72 mm Hg</td><td>07/08/2024</td></tr><tr><th ID="vital6">Heart Rate</th><td>63 /min</td><td>07/08/2024</td></tr><tr><th ID="vital7">Weight-kg</th><td>88 kg</td><td>07/08/2024</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>Athens Office</td><td>340 N Milledge Ave Suite B Athens, GA 306013806</td><td>07/08/2024</td><td>Melissa Baughcum</td><td>Cirrhosis K74.60 ; Gastroesophageal reflux disease, unspecified whether esophagitis present K21.9 ; Fatty liver K76.0 ; History of benign carcinoid neoplasm of gastrointestinal tract Z86.012 ; Diverticulitis K57.92 ; Malignant neoplasm of female breast, unspecified estrogen receptor status, unspecified laterality, unspecified site of breast C50.919 and Colon cancer screening Z12.11</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">07/08/2024</td><td>Cirrhosis (ICD-10 - K74.60)</td><td>likely secondary to NASH, chronic serologies negative in 2013. No decompensation. EGD 3/2023 with no varices. No sequeala of disease. Her AST is mildly elevated, syntehtic function is normal. She was diagnosed with HER2 breast cancer, following with Dr. Bhargava. MRI 3/2024 with no lesions, no sequela of PHTN. Will get labs from Dr. Bhargava, check liver labs and US every 6 months. </td><td/><td/><td/></tr><tr><td ID="ref2">07/08/2024</td><td>Gastroesophageal reflux disease, unspecified whether esophagitis present (ICD-10 - K21.9)</td><td>EGD in 3/2023 with 2 cm hiatal hernia, reflux stable on omeprazole 20mg daily.</td><td/><td/><td/></tr><tr><td ID="ref3">07/08/2024</td><td>Fatty liver (ICD-10 - K76.0)</td><td>with advanced disease as above.</td><td/><td/><td/></tr><tr><td ID="ref4">07/08/2024</td><td>History of benign carcinoid neoplasm of gastrointestinal tract (ICD-10 - Z86.012)</td><td>duodenal polyp c/w carcinoid on EGD 11/2016. Repeat EGD 2019 with no concerning lesions and CT 2019 negative. Repeat EGD 5/2021 by Dr. West with a small duodenal polyp that was a benign lymphoid aggregate. Repeat EGD 3/2023 with normal duodenum. MRI 3/2024 is normal. </td><td/><td/><td/></tr><tr><td ID="ref5">07/08/2024</td><td>Diverticulitis (ICD-10 - K57.92)</td><td>on CT imaging in 2021 in the sigmoid, treated. Low dose fiber.</td><td/><td/><td/></tr><tr><td ID="ref6">07/08/2024</td><td>Malignant neoplasm of female breast, unspecified estrogen receptor status, unspecified laterality, unspecified site of breast (ICD-10 - C50.919)</td><td>recommended for chemo/radiation, she declines therapy for this but her repeat mammo is negative. Following with Dr. Bhargava. </td><td/><td/><td/></tr><tr><td ID="ref7">07/08/2024</td><td>Colon cancer screening (ICD-10 - Z12.11)</td><td>repeat colon 1/2023 with three TAs by Dr. Grow, repeat as needed due to age.</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 6 Months,This visit was provided by Melissa Baughcum, APRN under the indirect supervision of Dr. Kelly Grow, MD., Reason: Cirrhosis</td></tr><tr><td ID="futureAppt1">Provider Name:Melissa Baughcum, 01/27/2025 11:00:00 AM, 340 N Milledge Ave, Suite B, Athens, GA, 306013806, 706-548-0008</td></tr></tbody></table></div><h3><a name="id10" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>PATRICK, Sylvia E <span class="bold">DOB:</span> 09/29/1945 (78 yo F) <span class="bold">Acc No.</span> 3595788 <span class="bold">DOS:</span> 07/08/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>PATRICK, Sylvia E<br/><span class="bold">Account Number: </span>3595788</td><td align="right"><span class="bold">Provider: </span>Melissa Baughcum, ANP-BC</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>09/29/1945<span class="bold">   Age: </span>78 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>07/08/2024</td></tr><tr><td><span class="bold">Phone: </span>706-742-8585</td></tr><tr><td colspan="2"><span class="bold">Address: </span>2136 BEAVERDAM RD, WINTERVILLE, GA-30683-2811</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>Karen Dixon, NP </td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   6m f/u</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Today's Visit:</span>: <br/>       9/18/2019<br/>Ms. Sylvia Patrick is a 73 year old female with hx of small bowel carcinoid, diabetes, hyperlipidemia, reflux, and cirrhosis who presents for follow up. She continues to have multiple loose stools daily and frequent accidents. Colonoscopy prep in January was poor with thick liquid stool throughout. EGD showed showed no lesions suspicious for carcinoid. I suspect her symptoms are related to baseline constipation and overflow. We discussed bowel regimen at her last visit however she does not recall this. She is not taking fiber, miralax, or stool softeners. She saw recommendations on Youtube to decrease fluid intake during meals and has been limiting her water intake. No improvement in her symptoms.<br/><br/>CT A/P 1/2019 showed nodular contour of the liver, HS, and splenomegaly. At her last visit, we discussed that given these findings she likely has cirrhosis. She does not recall this conversation and is surprised with this information today. She had autoimmune serologies and Hep serologes in 2013 that were normal. Labs 1/2019 showe elevated alk pho 119 and AST 45. She has no varices no EGD 1/2019. No h/o ascites. No history of HE. Ammonia was normal in 3/2019. No liver lesion on CT.<br/><br/>Reflux is well controlled on PPI. No breakthrough symptoms. No dysphagia. TG<br/><br/>3/15/21<br/>Patient is a 75 yo F with suspected NASH cirrhosis who presents for follow up. First visit since 9/18/2019. She was admitted 12/2020 after a ground level fall and confusion, found to have concussion and occipital hematoma and monitored inpatient. Mentation cleared. It was noted she had gastric wall thickening on her Abd CT from 2019 along with changes c/w portal HTN. She had normal hemoglobin at 13.5, normal plaetlets, LFTs/albumin not checked. INR normal.<br/><br/>She reports recent labs in early March with her PCP that were normal. Most recent liver imaging 10/2019 with US with no liver lesion. No hx of HE. No ascites. She is due for EGD. TG<br/><br/>9/20/21<br/><br/>EGD 5/2021--no varices; mild chronic esophagitis and mild chronic gastritis, no H. pylori. Empiric dilation completed for dysphagia.<br/><br/>After her last appointment 3/2021 she requested add on colonoscopy as her prior colonoscopy 1/2019 was poor prep. Procedure added but had diverticulitis lter that month and Dr. West sent in Flagyl and Cipro. Was to have colonoscopy at the time of egd--not done-?<br/>9/16/2022<br/>Sylvia presents to establish care for history of nonalcoholic fatty liver disease cirrhosis, duodenal carcinoid, and diverticulosis.  Since her last visit in 2021 she has been lost to follow-up.  Her repeat EGD in May 2021 reveals a benign lymphoid aggregate in the duodenum with no recurrence of carcinoid, no varices.  Her last colonoscopy was in 2019 with poor prep and inability to make it to the cecum.  She does have a history of diverticulitis documented on CT with contrast in 2021 status post antibiotics with resolution.  She still has some bowel regularity and we have discussed adding fiber.  During that CT scan she was also found to have a cirrhotic appearing liver.  This was also noted on previous imaging in 2019.  Today she is here to establish care.  She is due for repeat colonoscopy.  She is due for blood work and ultrasound of her liver.  We have discussed the bowel regimen including low-dose fiber given her history of diverticulitis.  Today she is doing well otherwise.  MB<br/>2/9/2023<br/>Sylvia presents for follow-up of end-stage liver disease secondary to fatty liver and diverticulitis.  Since her last visit she is status post repeat colonoscopy.  She has 3 tubular adenomas and left-sided diverticulosis.  Her ultrasound in September shows cirrhosis but no new lesions, her labs show mild thrombocytopenia with normal liver enzymes normal T. bili.  She denies any sequela of liver disease.  She is taking psyllium at night.  She feels that the 2 capsules constipate her so she has decreased it to 1 capsule daily.  She is due for Barrett's screening in May 2023, we will schedule that today, she will be due for HCC screening and labs in March which we will also order today.  Today she is doing otherwise with no new GI complaints.  MB<br/>8/7/2023<br/>Mrs. Patrick presents for follow-up of end-stage liver disease.  Since her last visit she has been doing well with no sequela of her disease.  Her last EGD in March shows no varices, she does have a small hiatal hernia with reflux and gastritis.  She denies any ascites or symptoms of encephalopathy.  Her ultrasound in April shows stable fatty liver with no new lesions.  Her synthetic function is fairly intact.  Today she is due for repeat labs, she will be due for repeat ultrasound this fall.  She would be due for repeat EGD for Barrett's screening in 2 years.  She denies any new GI complaints.  MB<br/>1/8/2024<br/>Sylvia presents for follow-up of end-stage liver disease.  Since her last visit her labs show mildly elevated AST.  Her repeat ultrasound shows a cirrhotic appearing liver.  She is recently been diagnosed with HER2 positive breast cancer.  She declines chemo and radiation currently, she is considering hormone therapy with Dr. Barr cava.  Today given her liver enzyme elevation and diagnosis of new primary malignancy, I recommended MRI of her liver.  She would like to discuss with this with Dr. Bart gada and consider CT imaging as this is what typically ordered for her surveillance scans, I am okay with CT imaging as well.  Today she denies any new GI complaints.  MB<br/>7/8/2024<br/>Sylvia presents for follow-up of end-stage liver disease.  Her repeat MRI shows advanced disease with no lesion.  She has no sequela of her disease.  Today she agrees to repeat labs.  Will continue to screen her liver for HCC every 6 months.  She has no symptoms of Hg, ascites, and her synthetic function on her labs has been normal.  MB.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General/Constitutional</span>: <br/>      Denies Fever. Denies Weight gain. Denies Weight loss (dieting).   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Denies Urinary Incontinence. Denies Fecal incontinence.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Denies Chronic cough. Denies Shortness of breath. Denies Wheezing or asthma symptoms.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Denies Chest pain. Denies Heart racing/skipping. Denies High blood pressure.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> Bladder Surgery: tack, Date of Procedure: date unknown; 2012-05-15breast cancer 10/31/2023Breast biopsy, both breasts: benign, Date of Procedure: date unknown; 2012-05-15Breast Surgery, Date of Procedure: date unknown; 2016-10-19Colonoscopy, Date of Procedure: 2012,2011; 2012-05-15EGD, Date of Procedure: 2011; 2016-10-18Hysterectomy, Date of Procedure: date unknown; 2012-05-15Reduction mammoplasty, Date of Procedure: 1983; 2012-05-15Tonsillectomy, Date of Procedure: date unknown; 2016-10-19</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> No Hospitalization History.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father:   Family history of CAD , Family history of colon cancer , Family history of colon polyps , Family History of Prostate Cancer  . Migrated Family History:  Aunt: Abdominal Aneurysm , Family history of breast cancer  . Mother:   Abdominal Aneurysm , Asthma , Chronic obstructive pulmonary disease , Family history of acid reflux/GERD , Family history of Barrett's Esophagus , Hypertension , Myocardial Infarction  . Siblings:  Sister: Abdominal Aneurysm , Family history of bladder cancer , Family History of Bone Cancer , Family history of breast cancer , Family history of diabetes ,Brother: Family history of diabetes , Family history of liver disease  . </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingZofran 4 MG Tablet 1 tablet Orally Once a day Omeprazole 20 MG Capsule Delayed Release 1 capsule 30 minutes before morning meal Orally Once a day Lisinopril 10 mg  take 1 tablet (10 mg) by oral route once daily  QD Propranolol HCl 10 MG Tablet take 1 tablet (10 mg) by oral route QD Oral 3 Vitamin D (Ergocalciferol) 50000 UNIT Capsule  Oral  PEG-3350/Electrolytes 236 GM Solution Reconstituted as directed Orally once Medication List reviewed and reconciled with the patientTaking Zofran 4 MG Tablet 1 tablet Orally Once a day Taking Omeprazole 20 MG Capsule Delayed Release 1 capsule 30 minutes before morning meal Orally Once a day Taking Lisinopril 10 mg  take 1 tablet (10 mg) by oral route once daily  QD Taking Propranolol HCl 10 MG Tablet take 1 tablet (10 mg) by oral route QD Oral 3 Taking Vitamin D (Ergocalciferol) 50000 UNIT Capsule  Oral  Taking PEG-3350/Electrolytes 236 GM Solution Reconstituted as directed Orally once Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> Dander: Notes: Pet Dander - Allergy - Onset Date 10/19/2016Dust Mite: Allergy - Onset Date 10/19/2016SULFA (SULFONAMIDES): Allergy - Onset Date 05/15/2012no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 62 in, Wt: 194 lbs, BMI: 35.48 Index, BP: 155/72 mm Hg, HR: 63 /min, Wt-kg: 88 kg.<br/></td></tr></tbody></table></li></ul><span class="Underline">Past Vitals:</span><ul><li><table cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="italics">01/08/2024</span></td></tr><tr><td><span class="content_span">Ht: 62 in, Wt: 191 lbs</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">Physical Exam:</span><br/>      CONSTITUTIONAL: alert , in no acute distress , well developed, well nourished. EYES: Conjuntivae and eyelids appear normal , Sclerae : White without injection. HENT: <span class="bold">Head</span> , normocephalic , atraumatic. NECK/THYROID: normal appearance , no deformities , trachea midline. CHEST: breathing is unlabored without accessory muscle use. , normal breath sounds.. CARDIOVASCULAR: regular rate and rhythm , no murmurs, rubs, gallops. GASTROINTESTINAL <span class="bold">Abdomen</span> , soft, nontender, nondistended , normal bowel sounds. MUSCULOSKELETAL: normal gait and station , full range of motion. SKIN: no rashes , no suspicious lesions. NEUROLOGIC: oriented to person, place and time ,  , cranial nerves 2-12 grossly intact. PSYCH: normal mood with appropriate affect , speech clear. ORAL CAVITY: mucosa moist , no lesions. LUNGS: clear to auscultation bilaterally , no wheezes, rales, rhonchi. EXTREMITIES: full range of motion , no edema.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Gastroesophageal reflux disease, unspecified whether esophagitis present - K21.9 (Primary), EGD in 3/2023 with 2 cm hiatal hernia, reflux stable on omeprazole 20mg daily. 2. Cirrhosis - K74.60, likely secondary to NASH, chronic serologies negative in 2013. No decompensation. EGD 3/2023 with no varices. No sequeala of disease. Her AST is mildly elevated, syntehtic function is normal. She was diagnosed with HER2 breast cancer, following with Dr. Bhargava. MRI 3/2024 with no lesions, no sequela of PHTN. Will get labs from Dr. Bhargava, check liver labs and US every 6 months.  3. Fatty liver - K76.0, with advanced disease as above. 4. History of benign carcinoid neoplasm of gastrointestinal tract - Z86.012, duodenal polyp c/w carcinoid on EGD 11/2016. Repeat EGD 2019 with no concerning lesions and CT 2019 negative. Repeat EGD 5/2021 by Dr. West with a small duodenal polyp that was a benign lymphoid aggregate. Repeat EGD 3/2023 with normal duodenum. MRI 3/2024 is normal.  5. Diverticulitis - K57.92, on CT imaging in 2021 in the sigmoid, treated. Low dose fiber. 6. Malignant neoplasm of female breast, unspecified estrogen receptor status, unspecified laterality, unspecified site of breast - C50.919, recommended for chemo/radiation, she declines therapy for this but her repeat mammo is negative. Following with Dr. Bhargava.  7. Colon cancer screening - Z12.11, repeat colon 1/2023 with three TAs by Dr. Grow, repeat as needed due to age. </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Gastroesophageal reflux disease, unspecified whether esophagitis present</span> <br/>     <span class="Underline">Imaging: US Abdomen Limited (Ordered for 09/08/2024)</span><ul><li><table border="1"><tbody><tr><td><span class="content_span">ATTN: Liver</span></td></tr></tbody></table></li></ul></td></tr><tr><td/></tr><tr><td><span class="bold">2. Cirrhosis</span> <br/>     <span class="Underline">LAB: CMP Comp. Metabolic Panel (14)</span><br/>     <span class="Underline">LAB: CBC w/Diff</span><br/>     <span class="Underline">LAB: PT/INR</span></td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 6 Months,This visit was provided by Melissa Baughcum, APRN under the indirect supervision of Dr. Kelly Grow, MD. (Reason: Cirrhosis)</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td colspan="2"><content><span class="bold">Images:</span></content></td></tr></tbody></table></li></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: a.  Modifiers: ML</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by Melissa Baughcum , ANP-BC  on 07/08/2024 at 06:17 PM EDT</td></tr><tr><td valign="top">Electronically co-signed by Kelly Grow, MD on 07/10/2024 at 04:08 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Melissa Baughcum, ANP-BC</td><td align="right"><span class="bold">Date: </span>07/08/2024</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 12/18/2024 01:14 PM EST</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id11" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td>Today's Visit:</td><td/><td colspan="2"/><td><p>9/18/2019</p><p>Ms. Sylvia Patrick is a 73 year old female with hx of small bowel carcinoid, diabetes, hyperlipidemia, reflux, and cirrhosis who presents for follow up. She continues to have multiple loose stools daily and frequent accidents. Colonoscopy prep in January was poor with thick liquid stool throughout. EGD showed showed no lesions suspicious for carcinoid. I suspect her symptoms are related to baseline constipation and overflow. We discussed bowel regimen at her last visit however she does not recall this. She is not taking fiber, miralax, or stool softeners. She saw recommendations on Youtube to decrease fluid intake during meals and has been limiting her water intake. No improvement in her symptoms.</p><p>CT A/P 1/2019 showed nodular contour of the liver, HS, and splenomegaly. At her last visit, we discussed that given these findings she likely has cirrhosis. She does not recall this conversation and is surprised with this information today. She had autoimmune serologies and Hep serologes in 2013 that were normal. Labs 1/2019 showe elevated alk pho 119 and AST 45. She has no varices no EGD 1/2019. No h/o ascites. No history of HE. Ammonia was normal in 3/2019. No liver lesion on CT.</p><p>Reflux is well controlled on PPI. No breakthrough symptoms. No dysphagia. TG</p><p>3/15/21</p><p>Patient is a 75 yo F with suspected NASH cirrhosis who presents for follow up. First visit since 9/18/2019. She was admitted 12/2020 after a ground level fall and confusion, found to have concussion and occipital hematoma and monitored inpatient. Mentation cleared. It was noted she had gastric wall thickening on her Abd CT from 2019 along with changes c/w portal HTN. She had normal hemoglobin at 13.5, normal plaetlets, LFTs/albumin not checked. INR normal.</p><p>She reports recent labs in early March with her PCP that were normal. Most recent liver imaging 10/2019 with US with no liver lesion. No hx of HE. No ascites. She is due for EGD. TG</p><p>9/20/21</p><p>EGD 5/2021--no varices; mild chronic esophagitis and mild chronic gastritis, no H. pylori. Empiric dilation completed for dysphagia.</p><p>After her last appointment 3/2021 she requested add on colonoscopy as her prior colonoscopy 1/2019 was poor prep. Procedure added but had diverticulitis lter that month and Dr. West sent in Flagyl and Cipro. Was to have colonoscopy at the time of egd--not done-?</p><p>9/16/2022</p><p>Sylvia presents to establish care for history of nonalcoholic fatty liver disease cirrhosis, duodenal carcinoid, and diverticulosis.  Since her last visit in 2021 she has been lost to follow-up.  Her repeat EGD in May 2021 reveals a benign lymphoid aggregate in the duodenum with no recurrence of carcinoid, no varices.  Her last colonoscopy was in 2019 with poor prep and inability to make it to the cecum.  She does have a history of diverticulitis documented on CT with contrast in 2021 status post antibiotics with resolution.  She still has some bowel regularity and we have discussed adding fiber.  During that CT scan she was also found to have a cirrhotic appearing liver.  This was also noted on previous imaging in 2019.  Today she is here to establish care.  She is due for repeat colonoscopy.  She is due for blood work and ultrasound of her liver.  We have discussed the bowel regimen including low-dose fiber given her history of diverticulitis.  Today she is doing well otherwise.  MB</p><p>2/9/2023</p><p>Sylvia presents for follow-up of end-stage liver disease secondary to fatty liver and diverticulitis.  Since her last visit she is status post repeat colonoscopy.  She has 3 tubular adenomas and left-sided diverticulosis.  Her ultrasound in September shows cirrhosis but no new lesions, her labs show mild thrombocytopenia with normal liver enzymes normal T. bili.  She denies any sequela of liver disease.  She is taking psyllium at night.  She feels that the 2 capsules constipate her so she has decreased it to 1 capsule daily.  She is due for Barrett's screening in May 2023, we will schedule that today, she will be due for HCC screening and labs in March which we will also order today.  Today she is doing otherwise with no new GI complaints.  MB</p><p>8/7/2023</p><p>Mrs. Patrick presents for follow-up of end-stage liver disease.  Since her last visit she has been doing well with no sequela of her disease.  Her last EGD in March shows no varices, she does have a small hiatal hernia with reflux and gastritis.  She denies any ascites or symptoms of encephalopathy.  Her ultrasound in April shows stable fatty liver with no new lesions.  Her synthetic function is fairly intact.  Today she is due for repeat labs, she will be due for repeat ultrasound this fall.  She would be due for repeat EGD for Barrett's screening in 2 years.  She denies any new GI complaints.  MB</p><p>1/8/2024</p><p>Sylvia presents for follow-up of end-stage liver disease.  Since her last visit her labs show mildly elevated AST.  Her repeat ultrasound shows a cirrhotic appearing liver.  She is recently been diagnosed with HER2 positive breast cancer.  She declines chemo and radiation currently, she is considering hormone therapy with Dr. Barr cava.  Today given her liver enzyme elevation and diagnosis of new primary malignancy, I recommended MRI of her liver.  She would like to discuss with this with Dr. Bart gada and consider CT imaging as this is what typically ordered for her surveillance scans, I am okay with CT imaging as well.  Today she denies any new GI complaints.  MB</p><p>7/8/2024</p><p>Sylvia presents for follow-up of end-stage liver disease.  Her repeat MRI shows advanced disease with no lesion.  She has no sequela of her disease.  Today she agrees to repeat labs.  Will continue to screen her liver for HCC every 6 months.  She has no symptoms of Hg, ascites, and her synthetic function on her labs has been normal.  MB</p></td></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td rowspan="14">Physical Exam</td><td>CONSTITUTIONAL:</td><td colspan="2">alert , in no acute distress , well developed, well nourished</td><td rowspan="14"/></tr><tr><td>EYES:</td><td colspan="2">Conjuntivae and eyelids appear normal , Sclerae : White without injection</td></tr><tr><td>HENT:</td><td colspan="2">Head , normocephalic , atraumatic</td></tr><tr><td>NECK/THYROID:</td><td colspan="2">normal appearance , no deformities , trachea midline</td></tr><tr><td>CARDIOVASCULAR:</td><td colspan="2">regular rate and rhythm , no murmurs, rubs, gallops</td></tr><tr><td>CHEST:</td><td colspan="2">breathing is unlabored without accessory muscle use. , normal breath sounds.</td></tr><tr><td>LUNGS:</td><td colspan="2">clear to auscultation bilaterally , no wheezes, rales, rhonchi</td></tr><tr><td>GASTROINTESTINAL</td><td colspan="2">Abdomen , soft, nontender, nondistended , normal bowel sounds</td></tr><tr><td>NEUROLOGIC:</td><td colspan="2">oriented to person, place and time ,  , cranial nerves 2-12 grossly intact</td></tr><tr><td>SKIN:</td><td colspan="2">no rashes , no suspicious lesions</td></tr><tr><td>EXTREMITIES:</td><td colspan="2">full range of motion , no edema</td></tr><tr><td>MUSCULOSKELETAL:</td><td colspan="2">normal gait and station , full range of motion</td></tr><tr><td>PSYCH:</td><td colspan="2">normal mood with appropriate affect , speech clear</td></tr><tr><td>ORAL CAVITY:</td><td colspan="2">mucosa moist , no lesions</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>